Plasma carnitine in HIV-associated neuropathy

AIDS. 2001 Nov 9;15(16):2207-8. doi: 10.1097/00002030-200111090-00025.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Randomized Controlled Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Anti-HIV Agents / adverse effects
  • Carnitine / blood*
  • Dideoxynucleosides / adverse effects
  • HIV Infections / complications*
  • HIV Infections / drug therapy
  • Humans
  • Nerve Growth Factor / genetics
  • Nerve Growth Factor / therapeutic use*
  • Peripheral Nervous System Diseases / chemically induced
  • Peripheral Nervous System Diseases / drug therapy*
  • Reverse Transcriptase Inhibitors / adverse effects

Substances

  • Anti-HIV Agents
  • Dideoxynucleosides
  • Reverse Transcriptase Inhibitors
  • Nerve Growth Factor
  • Carnitine